Scholarlink

Tuberculosis (TB) and psychiatric illnesses frequently coexist, creating significant challenges in diagnosis, treatment adherence, and overall patient outcomes. Individuals with psychiatric disorders are at increased risk of TB due to shared biological, psychological, and socioeconomic vulnerabilities. At the same time, TB itself can worsen mental health through stigma, prolonged treatment, and social isolation. The coexistence of these conditions is further complicated by poor treatment adherence, cognitive impairment, substance use, social disadvantage, and drug–drug interactions between anti-tubercular and psychotropic medications necessitating careful therapeutic monitoring. Integrated care models that incorporate multidisciplinary collaboration, mental health screening, psychoeducation, nursing support, telepsychiatry, and patient-centric interventions are essential to improving outcomes. Addressing stigma, financial barriers, and social determinants of health can further enhance adherence and quality of life. A holistic and coordinated approach is therefore crucial for optimizing treatment outcomes in patients with comorbid TB and psychiatric illnesses.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Navigating Treatment Challenges: Tuberculosis in Patients with Psychiatric Illnesses

  • 章节

  • 发表日期：

    2026年

查看全文
  • Jawahar Singh,
  • Mahak Aggarwal,
  • Avnika Bansal,
  • Ramandeep Kaur,
  • Soumya Swaroop Sahoo

摘要

Tuberculosis (TB) and psychiatric illnesses frequently coexist, creating significant challenges in diagnosis, treatment adherence, and overall patient outcomes. Individuals with psychiatric disorders are at increased risk of TB due to shared biological, psychological, and socioeconomic vulnerabilities. At the same time, TB itself can worsen mental health through stigma, prolonged treatment, and social isolation. The coexistence of these conditions is further complicated by poor treatment adherence, cognitive impairment, substance use, social disadvantage, and drug–drug interactions between anti-tubercular and psychotropic medications necessitating careful therapeutic monitoring. Integrated care models that incorporate multidisciplinary collaboration, mental health screening, psychoeducation, nursing support, telepsychiatry, and patient-centric interventions are essential to improving outcomes. Addressing stigma, financial barriers, and social determinants of health can further enhance adherence and quality of life. A holistic and coordinated approach is therefore crucial for optimizing treatment outcomes in patients with comorbid TB and psychiatric illnesses.